Lupin Limited has informed the Exchange regarding a press release dated December 22, 2022, titled "Lupin Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Four Lots of Quinapril Tablets due to potential presence of N-Nitroso-QuinaprilImpurity.".